RIA

PHYSICIANS FINANCIAL SERVICES, INC.

SEC Registered Investment Advisor filing as an institutional investment manager under CIK #0001665518 Mixed CIK: 0001665518
13F Score ?
30
3Y · Top 10 · Mgr Wt
13F Score ?
20
7Y · Top 10 · Mgr Wt
S&P 500 ?
80
Benchmark
$365K
AUM
+0.00%
2026 Q1
+11.31%
1-Year Return
+52.65%
Top 10 Concentration
+5.93%
Turnover
-2.01%
AUM Change
Since 2015
First Filing
104
# of Holdings

Fund Overview

13F Filed: 2026-04-15

As of 2026 Q1, Physicians Financial Services, Inc. manages $365K in reported 13F assets , holds 104 positions with +52.65% top-10 concentration , and delivered a 1-year return of +11.31% on its disclosed equity portfolio. Filing 13F reports since 2015.

About

Investment Strategy

Analytics Summary

Risk Profile

Official 13F Filings — SEC EDGAR Key personnel and Fund Overview may contain mistakes

Activity Summary — 2026 Q1

Q1 2026 13F Filed: Apr 15, 2026

Top Buys

% $
Stock % Impact
+0.74%
+0.65%
+0.57%
+0.36%
+0.34%
+0.27%

Top Sells

% $
Stock % Impact
-1.37%
-1.17%
Sold All 😨 Was: 0.68% -0.69%
-0.63%
-0.54%
-0.37%

Top Holdings

2026 Q1
Stock %
14.33%
6.51%
6.04%
5.63%
5.37%
4.29%
View All Holdings

Activity Summary

Latest
Market Value $365K
AUM Change -2.01%
New Positions 3
Increased Positions 49
Closed Positions 6
Top 10 Concentration +52.65%
Portfolio Turnover +5.93%
Alt Turnover +6.95%

Sector Allocation Trends

Quarterly History
Free View: Last 10 Quarters. Subscribe to see full history

Holdings Analysis

Size: % of Portfolio Color: Last Full-Quarter Return No data
Free: 10 quarters

Positions Dynamics

Visualizing Top 20 holdings weight history over the last 10 quarters.

Portfolio Analytics — Latest

PHYSICIANS FINANCIAL SERVICES, INC. risk dashboard covering volatility, beta, value-at-risk, drawdowns, concentration, factor tilts, benchmark comparison, and stress testing for the latest disclosed portfolio.

Risk access
Building institutional risk profile...
Guru Intelligence Hub Pro
Real-time Analytics
High-Conviction Alpha
AAPL 92.4
NVDA 88.1
MSFT 74.3
Strategy Guardian
Style Drift 0.12
Sector Rotation 0.38

Tracking institutional benchmark deviation

Scenario Lab
2008 GFC -32.4%
Covid-19 -18.1%
2022 Bear -24.7%
Unlock the full Guru Intelligence Hub
Real conviction scores for every holding  ·  Strategy Guardian alerts  ·  Live Scenario Lab stress tests
Upgrade to Pro

Best Strategy vs. Benchmarks

AI Backtest: Auto-Optimizing...
Loading AI Backtest...
Don't be Fooled by Randomness
Access Alpha, Capture Ratios, and Batting Average calibrated for this specific strategy.
UPGRADE NOW
Nassim Taleb — author of Fooled by Randomness
Returns
--
Latest Quarter
--
1-Year Return
--
Ann. Return
Risk
--
Std Deviation
--
Max Drawdown
--
Beta vs SPY
Quality
--
Sharpe
--
Sortino
--
Win Rate
--
Payoff Ratio
Edge Metrics Last 10 quarters only
--
Alpha annualized
--
Up Capture
--
Down Capture

Strategy Backtester: PHYSICIANS FINANCIAL SERVICES, INC.

Replicate top holdings performance • Compare vs benchmarks • Optimize N

Find the best N! Test multiple portfolio sizes at once to discover the optimal configuration.

Risk insights! Identify periods when the fund lagged the benchmark – critical for timing entries.

⏱ Run Backtest

Liquid Glass Edition

0
Backtests Run
+127%
Avg. Return

👆 Click the button to launch tickers!

Don't Be Fooled by Randomness
Proven alpha spans cycles, not just 24 months. Unlock full history since 1999.
PRO ACCESS
Free Demo
Try the Backtester on Real Funds
Run full-history backtests on a curated 2-3 funds. See signal quality, drawdowns, and cycle behavior before you decide.
Underperformance Analysis — Top 10 Holdings vs SPY

Backtesting PHYSICIANS FINANCIAL SERVICES, INC.'s top 10 holdings against SPY identified 39 underperformance periods. Worst drawdown: 2022-08 – 2022-12 (-14.3% vs SPY, 5 quarters).

Avg. lag: -3.6% vs SPY Avg. duration: 1.6 quarters
Backtest Snapshot — Top 10 Holdings (Mn-Weighted)

The ticker-level breakdown shows how each of PHYSICIANS FINANCIAL SERVICES, INC.'s top holdings contributed to portfolio returns quarter by quarter. Strongest recent contributors inside the last 5 years of the quarterly Top 10 backtest window: AAPL (2021 Q2 – 2025 Q4, +20.3 pts), NVDA (2023 Q2 – 2025 Q4, +14.4 pts), GOOGL (2021 Q2 – 2025 Q4, +10.1 pts), WMT (2021 Q2 – 2025 Q4, +8.3 pts), MSFT (2021 Q2 – 2025 Q4, +5.4 pts) .

Strategy ann.: 11.2% SPY ann.: 14.7% Period: 2016–2026
Best Recent Contributors — Last 5Y
All 5 recent top contributors beat SPY, which means this fund's strongest recent return drivers also outperformed the index over the same window.
2021 Q2 – 2025 Q4 • 19Q in Top 10 Beat SPY
AAPL
+80%
SPY
+44%
Contrib
+20.3%
2023 Q2 – 2025 Q4 • 11Q in Top 10 Beat SPY
NVDA
+339%
SPY
+44%
Contrib
+14.4%
2021 Q2 – 2025 Q4 • 19Q in Top 10 Beat SPY
GOOGL
+153%
SPY
+44%
Contrib
+10.1%
2021 Q2 – 2025 Q4 • 19Q in Top 10 Beat SPY
WMT
+169%
SPY
+44%
Contrib
+8.3%
2021 Q2 – 2025 Q4 • 19Q in Top 10 Beat SPY
MSFT
+44%
SPY
+44%
Contrib
+5.4%
Stock return (green = beat SPY)   Stock return (red = lagged SPY)   SPY same period   Cumulative contribution during the last 5 years of the quarterly Mn-weighted Top 10 strategy

Frequently Asked Questions

What does Physicians Financial Services, Inc. invest in?
PHYSICIANS FINANCIAL SERVICES, INC. follows a planning‑led, long‑only investment approach in which asset allocation at the client level drives the structure of the underlying portfolios. The equity sleeve that appears in Form 13F is typically constructed as a Core Blend allocation using a mix of broad‑based ETFs and, to a lesser extent, individual stocks. Key elements of the approach, as inferred from regulatory filings and typical RIA practice, include: - Strategic asset allocation across equities, fixed income, and cash, tailored to each client’s financial plan and risk profile. - Use of diversified ETFs—such as U.S. total market, large‑cap, and style or sector funds—to obtain efficient, low‑cost exposure to the equity market. - Selective ownership of individual blue‑chip or high‑conviction stocks to complement ETF exposure, often in sectors such as technology, healthcare, financials, industrials, and consumer franchises. - An orientation toward long‑term wealth accumulation, with tactical changes implemented incrementally rather than through wholesale trading. The 13F‑reported holdings therefore tend to show a diversified set of ETFs and a modest roster of direct equity holdings, without the narrow factor or sector concentrations associated with specialist managers. Turnover across filings is usually low to moderate: core ETFs often persist across multiple quarters, while position sizes in individual securities and any satellite exposures are adjusted as markets move and client needs evolve. Within this analytics environment, the **13F Portfolio Composition** module can be used to break down PHYSICIANS FINANCIAL SERVICES, INC.’s disclosed positions by vehicle type (ETF versus single stock), sector, and market‑capitalisation band. When combined with the Portfolio Simulator and Backtesting Service, this allows allocators to construct a rules‑based historical replication of the equity sleeve and to examine how the firm’s allocation‑centric, Core Blend implementation has translated into observable capital trajectories over time.
What is Physicians Financial Services, Inc.'s AUM?
Physicians Financial Services, Inc. reported $365K in 13F assets as of 2026 Q1. Note: 13F AUM reflects only long equity positions reported to the SEC and may differ from total assets under management.
How concentrated is Physicians Financial Services, Inc.'s portfolio?
Physicians Financial Services, Inc. holds 104 disclosed positions. The top 10 holdings represent +52.65% of the reported portfolio, indicating a highly concentrated investment approach.
How to track Physicians Financial Services, Inc. 13F filings?
Track Physicians Financial Services, Inc.'s quarterly filings on SEC EDGAR or on this page — data is updated within days of each filing deadline. Subscribe to 13Foresight for position-change alerts.

Disclaimer: 13Foresight is not a registered investment adviser, broker-dealer, or financial planner. All information on this site is provided solely for informational and educational purposes and does not constitute investment advice, a solicitation, or a recommendation to buy or sell any security. Portfolio backtests shown on this page are hypothetical and simulated — they do not represent actual trading results and were constructed with the benefit of hindsight. Actual results would differ materially. 13F filings disclose only long equity positions valued above $10,000, submitted up to 45 days after quarter-end; they do not capture short positions, options, bonds, cash, private investments, or non-U.S. securities. A fund's backtest performance may not reflect its actual returns, as managers frequently generate alpha through strategies not visible in 13F data. Past performance is not indicative of future results. All data sourced from public SEC EDGAR filings. Use at your own risk. Full Terms of Use.

Full history →